Eliot M. Lurier, Chief Financial Officer at INTERLEUKIN GENETICS INC (ILI), bought 10,000 shares at $0.29 ($3K) on 2008-11-24, disclosed to the SEC on 2008-11-25.
Open-market purchase of $3k ILI by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.